Written question asked by Navendu Mishra (Labour) on Monday, 8 February 2021, in the House of Commons. It was due for an answer on Thursday, 11 February 2021 (named day). A holding answer was provided on Thursday, 11 February 2021. A substantive answer was provided by Nadhim Zahawi (Conservative) on Friday, 12 March 2021 on behalf of the Department of Health and Social Care.
Coronavirus: Vaccination
- Question
-
To ask the Secretary of State for Health and Social Care, what assessment he has made of the (a) potential merits of including ME/CFS on the list of neurological conditions in group 6 of the JCVI priority list and (b) consistency of GP decisions on including ME/CFS patients in group 6.
- Answer
-
The Joint Committee on Vaccination and Immunisation has not identified any robust data to indicate that, as a group, persons with myalgic encephalomyelitis/chronic fatigue syndrome are at higher risk of dying from COVID-19, therefore this group is not included as part of the prioritisation for phase one of the programme.
Secondary information
- Type
- Written question
- Reference
- 150966
- Session
- 2019-21
- Subjects
- ME/CFS General practitioners Vaccination Joint Committee on Vaccination and Immunisation Coronavirus
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2021-03-12 15:27:26 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/150966
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/150966
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/150966